Page last updated: 2024-08-21
dronabinol and km-233
dronabinol has been researched along with km-233 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ferreira, AM; Krishnamurthy, M; Moore, BM | 1 |
| Boehm, P; Divi, MK; Duntsch, C; Jones, T; Krishnamurthy, M; Moore, BM; Sills, A; Wood, G; Zhou, Q | 1 |
Other Studies
2 other study(ies) available for dronabinol and km-233
| Article | Year |
|---|---|
Synthesis and testing of novel phenyl substituted side-chain analogues of classical cannabinoids.
Topics: Binding Sites; Cannabinoids; Cell Line; Humans | 2003 |
Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cannabinoids; Carmustine; Cell Line, Tumor; Dronabinol; Drug Administration Schedule; Glioma; Humans; Inhibitory Concentration 50; Mice; Mice, SCID; Organ Culture Techniques | 2006 |